SCHEMBL10742244

SCHEMBL10742244

C#CC[S+]([O-])c1ccccc1-c1nc2cnncc2[nH]1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 9/20 0.37
▸ NPC1 O15118 8/20 0.37
▸ KDM4E B2RXH2 8/20 0.37
▸ RAB9A P51151 7/20 0.37
▸ GPR55 Q9Y2T6 1/20 0.37
▸ SMN1; SMN2 Q16637 7/20 0.34
▸ HPGD P15428 4/20 0.34
▸ NPSR1 Q6W5P4 3/20 0.34
▸ HSD17B10 Q99714 3/20 0.34
▸ GAA P10253 3/20 0.34
▸ PKM P14618 2/20 0.34
▸ MAPT P10636 2/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ GLA P06280 1/20 0.34
▸ HTT P42858 1/20 0.34
▸ PDE5A O76074 3/20 0.34
▸ NPBWR1 P48145 1/20 0.32
▸ GBA1 P04062 1/20 0.32
▸ CDK1 P06493 1/20 0.32
▸ CDK2 P24941 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10740157 0.89 ALDH1A1 (0.37) ALDH1A1NPC1KDM4ERAB9AGPR55
SCHEMBL9634414 0.85 PDE5A (0.40) ALDH1A1NPC1KDM4ERAB9AGPR55
SCHEMBL10739221 0.81 ALDH1A1 (0.33) ALDH1A1NPC1KDM4ERAB9AGPR55
SCHEMBL10735012 0.77 NPC1 (0.36) ALDH1A1NPC1KDM4ERAB9ASMN1; SMN2
SCHEMBL10742455 0.76 GAA (0.36) ALDH1A1NPC1KDM4ERAB9ASMN1; SMN2
SCHEMBL9635097 0.75 KDM4E (0.41) ALDH1A1NPC1KDM4ERAB9AGPR55
SCHEMBL10739358 0.73 PDE5A (0.39) ALDH1A1NPC1KDM4ERAB9AGPR55
SCHEMBL10736882 0.73 MAOB (0.48) PDE5A
SCHEMBL10740250 0.72 METAP2 (0.45) PDE5A
SCHEMBL11063370 0.71 PDE5A (0.48) ALDH1A1NPC1KDM4ERAB9AGPR55

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4654344-A ALSO AFFECT BLOOD PRESSURE AND MYOCARDIAL CONTRACTIONS MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1987-03-31 — — US disclosed
EP-0093951-B1 2-ARYL-TETRAAZAINDENES MERCK PATENT GmbH (DE) 1986-10-29 — — EP disclosed
US-4575505-A Pharmaceutical compositions containing 2-aryltetraazaindenes for treating ulcers or cardiac insufficiency or blood pressure abnormalities MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1986-03-11 — — US disclosed
US-4477454-A INDOTROPIC AGENTS MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1984-10-16 — — US disclosed
EP-0093951-A2 2-Aryl-tetraazaindenes MERCK PATENT GmbH (DE) 1983-11-16 — — EP disclosed
Send feedback